4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-21-030737
Director acquired 4,167 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bowden Christopher Director | 2021-03-04 | Grant or award | +4,167 | 4,167 | D | ||
| Derivatives | |||||||
| Bowden Christopher Director | 2021-03-04 | Grant or award · Stock Option (right to buy) | +31,250 | 31,250 | D | ||
Loading xslF345X03/doc4.xml…